Subscribe

DCI Blog

All
All

Duke Cancer Institute (DCI) Blog provides updates, organizational announcements, the latest in funding opportunities and information on upcoming conferences and symposiums. This blog also highlights inspiring patient stories and the accomplishments and achievements of DCI faculty and staff. Subscribers are invited to submit story ideas and other news of interest. Email submissions and feedback to Karen E. Butler, Director of Communications, Duke Cancer Institute.

Sammons To Speak On Metastatic Breast Cancer

Susan G. Komen® North Carolina Triangle to the Coast will host its fourth annual Young Researchers Roundtable Breakfast: Hearing the Metastatic Voice , bringing attention and urgency to metastatic breast cancer (MBC) treatment, support, and needed research. Metastatic breast cancer (MBC), also...

Dent Named Associate Director For Clinical Research, Breast Oncology

Medical oncologist Susan F. Dent, MD, FRCPC, was recently named associate director for clinical research for Breast Oncology and co-director of Duke Cardio-Oncology. “We are extremely excited to welcome Susan Dent, a world-class breast cancer researcher and physician, to Duke Cancer Institute and...

DiLalla Named To ACS Board Of Directors

The American Cancer Society recently announced the appointment of Gayle DiLalla, MD, Duke Women's Cancer Care Raleigh, to the newly established American Cancer Society Area Board of Directors supporting central and east North Carolina chapters. “We are honored to welcome Dr. Gayle DiLalla to the...

McDonnell Team Awarded $7 Million For Breast Cancer Study

A team of researchers led by Duke Cancer Institute scientist Donald McDonnell, PhD, has been awarded a Breast Cancer Research Program (BCRP) Innovator Award, totaling $7,368,485, by the United States Department of Defense Office of Congressionally Directed Medical Research Programs (CDMRP). The...

Researchers Make Progress Unlocking Breast Brain Metastasis

Each year nearly 150,000 Americans are diagnosed with metastatic cancer that has spread to the brain. The number is projected to rise. As a result of a larger aging population, combined with improvements in cancer screening and care, up to 30 percent of patients with solid tumor cancers can expect...

DCI Researchers Launch Trial To Help Breast Cancer Survivors With Diabetes

Rebecca Shelby, PhD , and Gretchen Kimmick, MD, MS , of Duke Cancer Institute recently launched a clinical trial — I HEAL — the findings of which could lead to significant improvements in clinical care and beneficial outcomes for breast cancer survivors with diabetes. The trial is evaluating the...

IBC Consortium Translates Research Into Action

The Duke Consortium for Inflammatory Breast Cancer (IBC) recently hosted its first-ever annual meeting — “Engaging Our Community in IBC Research and Awareness .” Held in partnership with the IBC Network Foundation , Duke Cancer Institute, Duke, Duke University School of Medicine, Department of...

IBC Consortium To Host First-Ever Annual Meeting (2.28.18)

In partnership with the Duke School of Medicine, Duke Cancer Institute, Duke Department of Surgery, and the IBC Network Foundation , the Duke Consortium for Inflammatory Breast Cancer (IBC) will host its first-ever Annual Meeting, “Engaging Our Community in IBC Research and Awareness,” on Wednesday...

Patient Navigator Receives Spirit Award

A luncheon event benefiting the Susan G. Komen North Carolina Triangle to the Coast (Komen NCTC) — Finding Solutions Through Science, Scholars, and Survivors — today brought together 300 nationally-recognized breast oncology researchers, local breast cancer survivors and patients, corporate...

Risk-Reducing Surgery Questioned For Some BRCA Mutation Carriers

Mutations in the BRCA gene correspond to a higher lifetime risk of developing breast and ovarian cancers, and many women who carry these mutations consider undergoing mastectomy or removal of the ovaries and fallopian tubes as preventive measures. But for the subset of women with BRCA mutations who...

Study Shows How BPA May Affect Inflammatory Breast Cancer

The chemical bisphenol A, or BPA, appears to aid the survival of inflammatory breast cancer cells, revealing a potential mechanism for how the disease grows, according to a study led by researchers in the Department of Surgery at Duke University School of Medicine and the Duke Cancer Institute ...

Reducing Radiation May Cut Breast Cancer Treatment Costs

More than half of older women with early stage breast cancer received more radiation therapy than what might be medically necessary, adding additional treatment and health care costs, according to a study led by Duke Cancer Institute researchers. The researchers found that the annual estimated cost...

Pages